SE453153B - Forfarande for beredning av en farmaceutisk, parenteral dosenhet av lyofiliserat natriumpiperacillin - Google Patents

Forfarande for beredning av en farmaceutisk, parenteral dosenhet av lyofiliserat natriumpiperacillin

Info

Publication number
SE453153B
SE453153B SE8200591A SE8200591A SE453153B SE 453153 B SE453153 B SE 453153B SE 8200591 A SE8200591 A SE 8200591A SE 8200591 A SE8200591 A SE 8200591A SE 453153 B SE453153 B SE 453153B
Authority
SE
Sweden
Prior art keywords
concentration
lyophilized
piperacillin
dosage unit
sodium piperacillin
Prior art date
Application number
SE8200591A
Other languages
English (en)
Swedish (sv)
Other versions
SE8200591L (sv
Inventor
B E Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE453153(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SE8200591L publication Critical patent/SE8200591L/
Publication of SE453153B publication Critical patent/SE453153B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8200591A 1981-03-26 1982-02-02 Forfarande for beredning av en farmaceutisk, parenteral dosenhet av lyofiliserat natriumpiperacillin SE453153B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (2)

Publication Number Publication Date
SE8200591L SE8200591L (sv) 1982-09-27
SE453153B true SE453153B (sv) 1988-01-18

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200591A SE453153B (sv) 1981-03-26 1982-02-02 Forfarande for beredning av en farmaceutisk, parenteral dosenhet av lyofiliserat natriumpiperacillin

Country Status (23)

Country Link
JP (1) JPS57159708A (ja)
AT (1) AT395533B (ja)
AU (1) AU549784B2 (ja)
BE (1) BE892541A (ja)
CA (1) CA1209477A (ja)
CH (1) CH652306A5 (ja)
DE (2) DE3208505A1 (ja)
DK (1) DK157976C (ja)
ES (1) ES8302455A1 (ja)
FR (1) FR2502624B1 (ja)
GB (1) GB2095551B (ja)
GR (1) GR78386B (ja)
HK (1) HK39189A (ja)
HU (1) HU186489B (ja)
IE (1) IE52936B1 (ja)
IL (1) IL64924A (ja)
IT (1) IT1147916B (ja)
LU (1) LU84031A1 (ja)
NL (1) NL192664C (ja)
NZ (1) NZ199632A (ja)
PL (1) PL130564B1 (ja)
SE (1) SE453153B (ja)
ZA (1) ZA82605B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
JP4836797B2 (ja) 2003-10-23 2011-12-14 大塚製薬株式会社 放出制御性無菌注射アリピプラゾール製剤および方法
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
AR067747A1 (es) 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd Metodos para producir suspension de aripiprazol y formulacion liofilizada
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
PL130564B1 (en) 1984-08-31
ATA92982A (de) 1992-06-15
DE19375106I2 (de) 2006-02-16
GB2095551B (en) 1984-10-03
IT8248034A0 (it) 1982-03-19
HU186489B (en) 1985-08-28
SE8200591L (sv) 1982-09-27
DE3208505C2 (ja) 1991-11-28
DK157976B (da) 1990-03-12
GB2095551A (en) 1982-10-06
IL64924A0 (en) 1982-04-30
NL192664C (nl) 1997-12-02
CH652306A5 (de) 1985-11-15
DK157976C (da) 1990-08-27
AT395533B (de) 1993-01-25
NL8201251A (nl) 1982-10-18
JPH0219804B2 (ja) 1990-05-07
JPS57159708A (en) 1982-10-01
HK39189A (en) 1989-05-19
FR2502624A1 (fr) 1982-10-01
CA1209477A (en) 1986-08-12
ES509234A0 (es) 1982-12-16
DE3208505A1 (de) 1982-10-21
GR78386B (ja) 1984-09-26
NL192664B (nl) 1997-08-01
PL235509A1 (ja) 1982-12-20
FR2502624B1 (fr) 1985-10-25
IE820703L (en) 1982-09-26
DK48382A (da) 1982-09-27
NZ199632A (en) 1985-07-12
AU549784B2 (en) 1986-02-13
ES8302455A1 (es) 1982-12-16
IE52936B1 (en) 1988-04-13
IT1147916B (it) 1986-11-26
AU7986582A (en) 1982-09-30
BE892541A (fr) 1982-09-20
IL64924A (en) 1985-07-31
LU84031A1 (de) 1982-07-08
ZA82605B (en) 1982-12-29

Similar Documents

Publication Publication Date Title
DE69617036T2 (de) Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
AU674015B2 (en) Injection and injection kit containing omeprazole and its analogs
BG61752B1 (bg) Аерозолни състави под налягане
DE2415101A1 (de) Pharmazeutische zusammensetzungen
HUT49280A (en) Ointment for the peroral administration of medicine and process for producing the composition
US3914419A (en) Two compartment one unit consecutively injectable liquid vitamin package
US4477452A (en) Composition of matter comprising a lyophilized preparation of a penicillin derivative
SE453153B (sv) Forfarande for beredning av en farmaceutisk, parenteral dosenhet av lyofiliserat natriumpiperacillin
EP0813407B1 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
DE60215129T2 (de) Esmolol-enthaltende zubereitungen
US4534977A (en) Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
CA1269205A (en) Adsorption-resistant peptide composition
US3634586A (en) Stable aqueous suspensions of ampicillin
EP0180303B1 (en) Parenteral composition
GB2029700A (en) Etomidate-containing compositions
EP0095751A1 (en) Secretin composition and method for preventing the adsorption of secretin
AU629142B2 (en) Aqueous elcatonin solution composition
CN104666244B (zh) 含巴西蜡的兽用抗寄生虫制剂
US4451458A (en) Method for the treatment of post-operative thrombosis
CA2236690A1 (en) Aqueous acyclovir formulation and method for storing same
WO1999025629A1 (en) Multicompartment container for combination products
CN206482781U (zh) 一种防混淆住院护理配药柜
DE2721034C2 (ja)
CA1079194A (en) Pharmaceutical composition for the prophylactic treatment of thrombosis
Lyarskiy et al. Use of glutaraldehyde for sterilization of medical products of thermally labile materials(toxicologic, analytic and physicomechanical studies).

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200591-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200591-9

Format of ref document f/p: F